{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:03:14Z","timestamp":1756166594921,"version":"3.44.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,25]]},"DOI":"10.7759\/cureus.90926","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T07:57:53Z","timestamp":1756108673000},"source":"Crossref","is-referenced-by-count":0,"title":["Downregulation of miRNA-590 and miRNA-182 in Early-Stage Mycosis Fungoides in Skin of Color Patients"],"prefix":"10.7759","author":[{"given":"Rania H","family":"Mahmoud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"El-Khalawany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rania","family":"Abdelghani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameh K","family":"Fawzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shymaa E","family":"Ayoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noha E","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze R","year":"2005","unstructured":"Willemze R, Jaffe ES, Burg G, et al.. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005, 105:3768-85. 10.1182\/blood-2004-09-3502","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze R","year":"2019","unstructured":"Willemze R, Cerroni L, Kempf W, Berti E, Facchetti F, Swerdlow SH, Jaffe ES. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood. 2019, 133:1703-14. 10.1182\/blood-2018-11-881268","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.5526","article-title":"Changing incidence trends of cutaneous T-cell lymphoma","volume":"149","author":"Korgavkar K","year":"2013","unstructured":"Korgavkar K, Xiong M, Weinstock M. Changing incidence trends of cutaneous T-cell lymphoma. JAMA Dermatol. 2013, 149:1295-9. 10.1001\/jamadermatol.2013.5526","journal-title":"JAMA Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-021-06241-6","article-title":"The impact of gender, age, race\/ethnicity, and stage on quality of life in a spectrum of cutaneous lymphomas","volume":"29","author":"Martinez XU","year":"2021","unstructured":"Martinez XU, Chowdhury A, Stiller T, et al.. The impact of gender, age, race\/ethnicity, and stage on quality of life in a spectrum of cutaneous lymphomas. Support Care Cancer. 2021, 29:6669-79. 10.1007\/s00520-021-06241-6","journal-title":"Support Care Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1172\/JCI24826","article-title":"Immunopathogenesis and therapy of cutaneous T cell lymphoma","volume":"115","author":"Kim EJ","year":"2005","unstructured":"Kim EJ, Hess S, Richardson SK, et al.. Immunopathogenesis and therapy of cutaneous T cell lymphoma. J Clin Invest. 2005, 115:798-812. 10.1172\/JCI24826","journal-title":"J Clin Invest"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival outcomes and prognostic factors in mycosis fungoides\/S\u00e9zary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal","volume":"28","author":"Agar NS","year":"2010","unstructured":"Agar NS, Wedgeworth E, Crichton S, et al.. Survival outcomes and prognostic factors in mycosis fungoides\/S\u00e9zary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal. J Clin Oncol. 2010, 28:4730-9. 10.1200\/JCO.2009.27.7665","journal-title":"J Clin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-0604","article-title":"Long-term outcomes of 1,263 patients with mycosis fungoides and S\u00e9zary syndrome from 1982 to 2009","volume":"18","author":"Talpur R","year":"2012","unstructured":"Talpur R, Singh L, Daulat S, et al.. Long-term outcomes of 1,263 patients with mycosis fungoides and S\u00e9zary syndrome from 1982 to 2009. Clin Cancer Res. 2012, 18:5051-60. 10.1158\/1078-0432.CCR-12-0604","journal-title":"Clin Cancer Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.08.073","article-title":"Outcomes and prognostic factors in African American and black patients with mycosis fungoides\/S\u00e9zary syndrome: retrospective analysis of 157 patients from a referral cancer center","volume":"83","author":"Geller S","year":"2020","unstructured":"Geller S, Lebowitz E, Pulitzer MP, Horwitz SM, Moskowitz AJ, Dusza S, Myskowski PL. Outcomes and prognostic factors in African American and black patients with mycosis fungoides\/S\u00e9zary syndrome: retrospective analysis of 157 patients from a referral cancer center. J Am Acad Dermatol. 2020, 83:430-9. 10.1016\/j.jaad.2019.08.073","journal-title":"J Am Acad Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.06.790","article-title":"Gender and racial disparities in mycosis fungoides","volume":"81","author":"Luther C","year":"2019","unstructured":"Luther C, McHargue C. Gender and racial disparities in mycosis fungoides. J Am Acad Dermatol. 2019, 81:AB215. 10.1016\/j.jaad.2019.06.790","journal-title":"J Am Acad Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08852.x","article-title":"Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome)","volume":"155","author":"Wong HK","year":"2011","unstructured":"Wong HK, Mishra A, Hake T, Porcu P. Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome). Br J Haematol. 2011, 155:150-66. 10.1111\/j.1365-2141.2011.08852.x","journal-title":"Br J Haematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.06.1193","article-title":"Variations in genetics, biology, and phenotype of cutaneous disorders in skin of color-part I: genetic, biologic, and structural differences in skin of color","volume":"87","author":"Brown-Korsah JB","year":"2022","unstructured":"Brown-Korsah JB, McKenzie S, Omar D, Syder NC, Elbuluk N, Taylor SC. Variations in genetics, biology, and phenotype of cutaneous disorders in skin of color-part I: genetic, biologic, and structural differences in skin of color. J Am Acad Dermatol. 2022, 87:1239-58. 10.1016\/j.jaad.2022.06.1193","journal-title":"J Am Acad Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.752817","article-title":"The role of microRNA in pathogenesis, diagnosis, different variants, treatment and prognosis of mycosis fungoides","volume":"11","author":"Wen P","year":"2021","unstructured":"Wen P, Xie Y, Wang L. The role of microRNA in pathogenesis, diagnosis, different variants, treatment and prognosis of mycosis fungoides. Front Oncol. 2021, 11:752817. 10.3389\/fonc.2021.752817","journal-title":"Front Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17768","article-title":"The emerging role of microRNAs in the molecular diagnosis of mycosis fungoides","volume":"180","author":"Querfeld C","year":"2019","unstructured":"Querfeld C. The emerging role of microRNAs in the molecular diagnosis of mycosis fungoides. Br J Dermatol. 2019, 180:984-5. 10.1111\/bjd.17768","journal-title":"Br J Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1261\/rna.2322506","article-title":"Post-transcriptional regulation of microRNA expression","volume":"12","author":"Obernosterer G","year":"2006","unstructured":"Obernosterer G, Leuschner PJ, Alenius M, Martinez J. Post-transcriptional regulation of microRNA expression. RNA. 2006, 12:1161-7. 10.1261\/rna.2322506","journal-title":"RNA"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.03.1500","article-title":"MicroRNA signatures in diagnosis and prognosis of cutaneous T-cell lymphoma","volume":"138","author":"Shen X","year":"2018","unstructured":"Shen X, Wang B, Li K, et al.. MicroRNA signatures in diagnosis and prognosis of cutaneous T-cell lymphoma. J Invest Dermatol. 2018, 138:2024-32. 10.1016\/j.jid.2018.03.1500","journal-title":"J Invest Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18102136","article-title":"Plasma miR-155, miR-203, and miR-205 are biomarkers for monitoring of primary cutaneous T-cell lymphomas","volume":"18","author":"Dus\u00edlkov\u00e1 N","year":"2017","unstructured":"Dus\u00edlkov\u00e1 N, Ba\u0161ov\u00e1 P, Pol\u00edvka J, et al.. Plasma miR-155, miR-203, and miR-205 are biomarkers for monitoring of primary cutaneous T-cell lymphomas. Int J Mol Sci. 2017, 18:2136. 10.3390\/ijms18102136","journal-title":"Int J Mol Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.815352","article-title":"Validation of a diagnostic microRNA classifier in cutaneous T-cell lymphomas","volume":"55","author":"Marstrand T","year":"2014","unstructured":"Marstrand T, Ahler CB, Ralfkiaer U, et al.. Validation of a diagnostic microRNA classifier in cutaneous T-cell lymphomas. Leuk Lymphoma. 2014, 55:957-8. 10.3109\/10428194.2013.815352","journal-title":"Leuk Lymphoma"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.flm.2017.11.002","article-title":"Biological functions of miR-590 and its role in carcinogenesis","volume":"4","author":"Dong Y","year":"2017","unstructured":"Dong Y, Qiu GB. Biological functions of miR-590 and its role in carcinogenesis. Front Lab Med. 2017, 4:173-6. 10.1016\/j.flm.2017.11.002","journal-title":"Front Lab Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3727\/096504013X13775486749335","article-title":"Enhancement of proliferation and invasion by MicroRNA-590-5p via targeting PBRM1 in clear cell renal carcinoma cells","volume":"20","author":"Xiao X","year":"2013","unstructured":"Xiao X, Tang C, Xiao S, Fu C, Yu P. Enhancement of proliferation and invasion by MicroRNA-590-5p via targeting PBRM1 in clear cell renal carcinoma cells. Oncol Res. 2013, 20:537-44. 10.3727\/096504013X13775486749335","journal-title":"Oncol Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.24726","article-title":"MicroRNA-590 promotes cervical cancer cell growth and invasion by targeting CHL1","volume":"115","author":"Chu Y","year":"2014","unstructured":"Chu Y, Ouyang Y, Wang F, et al.. MicroRNA-590 promotes cervical cancer cell growth and invasion by targeting CHL1. J Cell Biochem. 2014, 115:847-53. 10.1002\/jcb.24726","journal-title":"J Cell Biochem"},{"key":"ref21","article-title":"Roles of miR-590-5p and miR-590-3p in the development of hepatocellular carcinoma","volume":"33","author":"Yang H","year":"2013","unstructured":"Yang H, Zheng W, Zhao W, Guan C, An J. Roles of miR-590-5p and miR-590-3p in the development of hepatocellular carcinoma. Nan Fang Yi Ke Da Xue Xue Bao. 2013, 33:804-11.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-015-9864-2","article-title":"Relationship of immunohistochemistry, copy number aberrations and epigenetic disorders with BRCAness pattern in hereditary and sporadic breast cancer","volume":"15","author":"Murria Estal R","year":"2016","unstructured":"Murria Estal R, Palanca Suela S, de Juan Jim\u00e9nez I, et al.. Relationship of immunohistochemistry, copy number aberrations and epigenetic disorders with BRCAness pattern in hereditary and sporadic breast cancer. Fam Cancer. 2016, 15:193-200. 10.1007\/s10689-015-9864-2","journal-title":"Fam Cancer"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.306","article-title":"MiR-590-5p inhibits colorectal cancer angiogenesis and metastasis by regulating nuclear factor 90\/vascular endothelial growth factor A axis","volume":"7","author":"Zhou Q","year":"2016","unstructured":"Zhou Q, Zhu Y, Wei X, et al.. MiR-590-5p inhibits colorectal cancer angiogenesis and metastasis by regulating nuclear factor 90\/vascular endothelial growth factor A axis. Cell Death Dis. 2016, 7:e2413. 10.1038\/cddis.2016.306","journal-title":"Cell Death Dis"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-023-02972-0","article-title":"The emerging role of MicroRNA-182 in tumorigenesis; a promising therapeutic target","volume":"23","author":"Sameti P","year":"2023","unstructured":"Sameti P, Tohidast M, Amini M, Bahojb Mahdavi SZ, Najafi S, Mokhtarzadeh A. The emerging role of MicroRNA-182 in tumorigenesis; a promising therapeutic target. Cancer Cell Int. 2023, 23:134. 10.1186\/s12935-023-02972-0","journal-title":"Cancer Cell Int"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijwd.2021.04.001","article-title":"Assessment of skin of color and diversity and inclusion content of dermatologic published literature: an analysis and call to action","volume":"7","author":"Wilson BN","year":"2021","unstructured":"Wilson BN, Sun M, Ashbaugh AG, Ohri S, Yeh C, Murrell DF, Murase JE. Assessment of skin of color and diversity and inclusion content of dermatologic published literature: an analysis and call to action. Int J Womens Dermatol. 2021, 7:391-7. 10.1016\/j.ijwd.2021.04.001","journal-title":"Int J Womens Dermatol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.08.057","article-title":"Defining early mycosis fungoides","volume":"53","author":"Pimpinelli N","year":"2005","unstructured":"Pimpinelli N, Olsen EA, Santucci M, et al.. Defining early mycosis fungoides. J Am Acad Dermatol. 2005, 53:1053-63. 10.1016\/j.jaad.2005.08.057","journal-title":"J Am Acad Dermatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2013.04.018","article-title":"A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome","volume":"49","author":"Benton EC","year":"2013","unstructured":"Benton EC, Crichton S, Talpur R, et al.. A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome. Eur J Cancer. 2013, 49:2859-68. 10.1016\/j.ejca.2013.04.018","journal-title":"Eur J Cancer"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2017.08.144","article-title":"RUNX3 inhibits the proliferation and metastasis of gastric cancer through regulating miR-182\/HOXA9","volume":"96","author":"Yu J","year":"2017","unstructured":"Yu J, Tian X, Chang J, Liu P, Zhang R. RUNX3 inhibits the proliferation and metastasis of gastric cancer through regulating miR-182\/HOXA9. Biomed Pharmacother. 2017, 96:782-91. 10.1016\/j.biopha.2017.08.144","journal-title":"Biomed Pharmacother"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2019.60.2.148","article-title":"MiR-182-5p knockdown targeting PTEN inhibits cell proliferation and invasion of breast cancer cells","volume":"60","author":"Zhao YS","year":"2019","unstructured":"Zhao YS, Yang WC, Xin HW, Han JX, Ma SG. MiR-182-5p knockdown targeting PTEN inhibits cell proliferation and invasion of breast cancer cells. Yonsei Med J. 2019, 60:148-57. 10.3349\/ymj.2019.60.2.148","journal-title":"Yonsei Med J"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-012-2467-3","article-title":"Up-regulation of miR-182 expression after epigenetic modulation of human melanoma cells","volume":"20","author":"Liu S","year":"2013","unstructured":"Liu S, Howell PM, Riker AI. Up-regulation of miR-182 expression after epigenetic modulation of human melanoma cells. Ann Surg Oncol. 2013, 20:1745-52. 10.1245\/s10434-012-2467-3","journal-title":"Ann Surg Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/385925-downregulation-of-mirna-590-and-mirna-182-in-early-stage-mycosis-fungoides-in-skin-of-color-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T07:57:53Z","timestamp":1756108673000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/385925-downregulation-of-mirna-590-and-mirna-182-in-early-stage-mycosis-fungoides-in-skin-of-color-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.90926","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,25]]}}}